Clinical Trial Update: Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This dose-escalation Phase 1 trial evaluated the safety and tolerability of combining Sorafenib with Irinotecan in pediatric patients with solid tumors; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Ewing Sarcoma
• Neuroblastoma
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Irinotecan (Irinotecan)
• Sorafenib (Sorafenib)

Snippet

Sponsor: HMeany | Conditions: Rhabdomyosarcoma and Other Soft Tissue Sarcomas, Ewing's Sarcoma Family of Tumors | Phase 1 | Status: COMPLETED